Friday, April 19, 2024
4/19/2024
Drug Abuse Alternatives Center (DAAC) is requesting $518,222 per year for up to three years from the SAMHSA CSAT to expand MAT services to include the delivery of combined buprenorphine-naloxone and other FDA-approved Medication Assisted Treatments (MAT) within a Methadone clinic in combination with integrated primary care and behavioral health, substance abuse treatment, case management, care coordination and aftercare services for persons with an opioid use disorder (OUD). Project activities will take place in Sonoma County, CA, and the primary target population will be low-income adult men and women with an OUD and/or co-occurring mental health disorder who 1) are high-risk IV drug users and/or prescription opioid users, and 2) who are clients of DAAC’s adult residential, outpatient and/or intensive perinatal outpatient substance use disorder treatment programs. DAAC’s project will increase access to additional MAT services and lead to a decrease in illicit opioid drug use and prescription opioid misuse for 100 unduplicated individuals annually and 300 over the entire project period. DAAC will provide MAT within a comprehensive, integrated substance abuse treatment and recovery support system that includes a Methadone clinic, residential, outpatient and intensive outpatient, continuing and aftercare, transitional housing, and vocational and employment services. MAT Project services will be coordinated with psychosocial therapies and recovery supports, and clients will be directly linked into ongoing MAT and primary care in partnership with local Federally Qualified Health Centers (FQHCs) and Opioid Treatment Programs (OTP). The treatment and service plans that result from this project will be implemented and monitored by certified counselors, medical and mental health clinicians, and case managers acting within their appropriate scope of practice. DAAC’s programs will utilize evidence-based practices including providing integrated services so that MAT, substance use and mental health disorders, and trauma and abuse can be treated in the most effective manner. DAAC’s Methadone Clinic is CARF Accredited and is a DHCS licensed and certified program. DAAC’s programs are DHCS designated ASAM Level of Care 3.1 and 3.5; 1.0 and 2.1 outpatient programs and is a DMC Certified provider. Over the three-year grant period, DAAC will establish on-site MAT services for 300 people with OUD enrolled in detox, residential, outpatient and/or intensive outpatient substance abuse treatment program; enhance DAAC’s comprehensive, multi-modality treatment model to accomplish positive outcome for adults with OUD; and enhance DAAC’s service delivery model to improve substance use disorder services and coordinate services necessary for MAT patients to achieve and sustain recovery. Outcomes for participants will include increased MAT access and participation, decreased substance abuse, decreased criminal justice system involvement, and overall improvements in emotional and mental health.
HHS’ Tracking Accountability in Government Grants System (TAGGS) website provides access to detailed descriptions of grants, loans, aggregated direct payments and other types of financial assistance awarded by the HHS Operating Divisions (OPDIVs) and the Office of the Secretary Staff Divisions (STAFFDIVs).
